GFAT1 Activators

GFAT1 (Glutamine:fructose-6-phosphate amidotransferase 1) is the rate-limiting enzyme in the hexosamine biosynthetic pathway (HBP), which plays a significant role in nutrient sensing and cellular responses to glucose availability. The HBP leads to the production of UDP-N-acetylglucosamine (UDP-GlcNAc), a critical substrate for protein glycosylation, affecting various cellular functions. Due to the absence of direct chemical activators, the focus is on compounds that modulate metabolic pathways and stress responses relevant to GFAT1's functions.

The chemicals listed above target various aspects of cellular metabolism that could indirectly modulate GFAT1 activity. Metformin and Berberine, known for their effects on AMPK and glucose metabolism, may influence GFAT1 through alterations in cellular energy status. Glucosamine, as a substrate for the HBP, provides a direct link to GFAT1 activity. Inhibitors of glutamine-utilizing enzymes like Azaserine and DON could indirectly affect GFAT1 by altering glutamine metabolism. Furthermore, Nicotinamide Riboside, as an NAD+ precursor, and Rapamycin, an mTOR inhibitor, represent avenues for indirect modulation through broader metabolic effects. Compounds like Acetyl-L-carnitine and Fenofibrate, affecting mitochondrial function and lipid metabolism respectively, could also intersect with GFAT1's metabolic pathways. PPAR-gamma agonists like Rosiglitazone may modulate glucose handling processes involving GFAT1.Additionally, 2-Deoxy-D-glucose, a glycolysis inhibitor, and Tunicamycin, which affects glycosylation pathways, offer insights into the broader regulatory network involving GFAT1.